"label","sentence"
2,"However, it is not clear whether the anti-virus 185 immune response would be affected after Tocilizumab treatment."
0,"However, the use of ribavirin is associated with significant toxicity, including hemolysis and reduced hemoglobin levels [81] , indicating that ribavirin should be used with caution as a treatment for COVID-19."
4,"According to preliminary reports [50 , 51] from the Chinese authorities suggesting that approxi-mately 100 infected patients treated with chloroquine experienced a more rapid decline in fever and improvement of lung computed tomography (CT) images and required a shorter time to recover compared with control groups, with no obvious serious adverse effects, the Chinese medical advisory board has suggested chloroquine inclusion in the SARS-CoV-2 treatment guidelines."
4,"Notably, inhibition of mTOR with sirolimus reduced MERS-CoV infection by ~60% in cell-based studies 21 ."
2,"Chlorpromazine, an antipsychotic (via dopamine D2 antagonism) dating from the 1950s, is also a potent endocytosis inhibitor (which may explain some of its marked side effects, which can include low white blood cell levels)."
4,"Hydroxychloroquine (HCQ) has emerged as a controversial and potential candidate therapy for COVID-19 [4, 5] ; however, the mechanisms of HCQ antiviral action are unclear."
4,"They showed that chloroquine could reduce the length of hospital stay and improve the evolution of COVID-19 pneumonia [4 , 6] , leading to recommend the administration of 500 mg of chloroquine twice a day in patients with mild, moderate and severe forms of COVID-19 pneumonia."
4,"Heparin, a well-tolerated anticoagulant drug, has been used successfully for over 80 years with limited and manageable side effects."
4,"For example, a docking study of lopinavir along with other HIV proteinase inhibitors of the CoV proteinase (PDBID 1UK3) suggests atazanavir and ritonavir, which are listed in the present prediction results, may inhibit the CoV proteinase in line with the inhibitory potency of lopinavir (14) ."
4,"11 In response to SARS-CoV-2, the Substance Abuse and Mental Health Services Administration has developed emergency regulations to support medication for opioid use disorder via telehealth, 12 and temporarily waived the requirement for in-person physical exam to be able to initiate buprenorphine."
2,"The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses angiotensinconverting enzyme II (ACE2) receptor to enter the host cell and the serine protease TMPRSS2 for virus spike protein priming (2) ."
4,"Added value of this studyOur study is the first randomised, double-blind, placebocontrolled clinical trial assessing the effect of intravenous remdesivir in adults admitted to hospital with severe COVID-19."
4,"The efficacy of aprotinin (and of remdesivir, which is investigated 466against SARS-CoV-2 in clinical trials) can be further enhanced by therapeutic 467concentrations of the proton pump inhibitor omeprazole."
4,"Although these data are encouraging for the potential role of hydroxychloroquine against SARS-CoV-2, we caution against solely relying on these data to support dosing regimens for patients."
2,"The S1/S2 cleavage site of SARS-2-S harbors several arginine residues (multibasic), which indicates high cleavability."
0,"The existence of hydroxychloroquine failure in two patients (mother and son) is more suggestive of the last mechanism of resistance."
2,"Hydroxychloroquine was started with the same dosing regimen as Case 1, along with azithromycin and ceftriaxone."
2,"Recommendation 8: In severe COVID-19 patients with coagulation dysfuntion, a TEG heparinase comparison test is recommended to monitor unfractionated heparin dosage ::: Anticoagulation therapyMost COVID-19 patients with coagulation dysfunction receive heparin."
4,"For this reason, it can be suggested that 112 patients with vascular prosthesis could be considered a selected subgroup, in which, in case of 113 COVID19, it is probably necessary to start an aggressive treatment with heparin at therapeutic 114 dosage."
4,"On 17 February, the Chinese State Council announced that chloroquine phosphate — a structural analogue of quinine, originally extracted from the bark of cinchona trees — can be used for treating COVID-19 patients."
2,"Fifteen heparin anticoagulated plasma samples (from day 2 to 22 post-symptom onset) 77 from SARS-CoV-2 infected patients were analyzed (Table S1 )."
4,"The interventions included arbidol (1 study) [36] , arbidol and lopinavir/ritonavir (1 study) [37] , hydroxychloroquine (4 studies) [28, 32, 37, 40] , interferon and corticosteroid (2 studies) [12, 30] , lopinavir/ritonavir (2 studies) [36, 38] , lopinavir/ritonavir plus ribavirin and corticosteroids (2 studies) [10, 35] , ribavirin (4 studies) [26, 31, 33, 41] , ribavirin and interferon (3 studies) [29, 34, 39] , ribavirin and corticosteroids (1 study) [31] ( Table 1 ).The primary outcomes were mortality reported in 10 studies (4,282 patients) [10, 12, 26, 29, 31, 34, 35, 38, 39, 41] , virological clearance reported in 7 studies (663 patients) [27, 32, [35] [36] [37] [38] 40] , clinical improvement reported in 1 study (199 patients) [38] ."
0,"In fact, the only data assessing oseltamivir activity against coronaviruses demonstrated it to be ineffective at inhibiting SARS-CoV-1, even at a concentration of 10 000 µM/L [56]."
4,"After the outbreak of severe acute respiratory syndrome (SARS) in 2003, screening of approved drugs identified at least two human immunodeficiency virus type-1 (HIV-1) protease inhibitors, lopinavir and nelfinavir, as compounds that inhibited SARS-CoV replication in vitro 3, 4 ."
2,"Remdesivir is presently in clinical trial for Ebola and SARS-CoV-2 infection (Li and De Clercq 2020)."
4,"In children, epinephrine is the first vasoactive of choice for septic shock."
2,"Fourth, we were unable to assess hormone profiles in our cohort, including total testosterone, luteinizing hormone, and follicle stimulating hormone, which could provide an assessment of testicular function."
4,"Discussion The research letter, written by a group of Chinese researchers, studied the effect of chloroquine in vitro, using Vero E6 cells infected by SARS-CoV-2 at a multiplicity of infection (MOI) of 0.05."
2,"Because of the structural conservation on the polymerase catalytic chamber between 2019-nCoV and HCV ns5b polymerase, as well as the likely similar mechanisms of action of remdesivir and sofosbuvir (12, 16) (2'-F-2'-C-methyluridine monophosphate prodrug which targets HCV 45 author/funder."
4,"Janus kinase (JAK) inhibitors such as Baricitinib, Fedratinib, and Ruxolitinib, indicated for Rheumatoid Arthritis and Myelofibrosis, have been tested in xenograft models for Chimeric Antigen Receptor (CAR) T-cell therapy induced CRS 25 ."
4,"The subfractionation of existing heparin preparations against anticoagulant activities (with proven low-toxicity profiles, good bioavailability and industrial-scale manufacturing) for off-label pathologies, provides an attractive strategy for quickly and effectively responding to COVID-19 and for the development of next generation heparin-based therapeutics."
4,"(13)Currently, tocilizumab is available in South Africa for patients with severe Covid-19 and ARDS under the Monitored Emergency use of Unregistered and Investigational Interventions framework."
2,"Trial design This trial is a double-blind placebo-controlled multicenter international randomized-controlled trial designed to evaluate the superiority of hydroxychloroquine versus placebo."
2,"The Gilead’s NUC inhibitor, remdesivir, having a similar chemical structure to HIV reverse-transcriptase inhibitors, is currently being tested in clinical trials for 2019-nCov (SARS-CoV-2), while a drug targeting the spike glycoprotein has also been tested in phase I trials for the treatment of HIV and SARS-CoV.4CRISPR/Cas13d is an RNA-guided, RNA-targeting CRISPR system."
2,"Any clinical impact of remdesivir on COVID-19 remains unknown, and scientists are waiting patiently the final results of these ongoing trials."
2,"According to the current guidelines, [13] the diagnosis of acute pancreatitis requires at least two of the three following signs: 1) abdominal pain, 2) amylase or lipase >3 times the upper normal limit, and 3) characteristic findings on diagnostic imaging."
0,"However, as instructed by the Guideline for the Diagnosis and Treatment of Novel Coronavirus Pneumonia (the 5th edition) released by the National Health Commission of the People’s Republic of China, chlorhexidine, which is commonly used as mouthrinse in dental practice, may not be effective to kill 2019-nCoV."
2,"Like Remdesivir, these nucleotide analogs are proposed to inhibit the viral RdRp through non-obligate RNA chain termination, a mechanism that requires the conversion of the parent compound to the triphosphate active form (33)."
2,"There was a single SAE potentially attributed to remdesivir, which was infusion-related hypotension in a 41-year-old man (50) .Published data describing use of remdesivir for COVID-19 include a case report and case series (60) (61) (62) ."
4,"The antimalarials hydroxychloroquine (HCQ) and chloroquine (CQ) have demonstrated antiviral activity against severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) in vitro and in small, poorly controlled or uncontrolled clinical studies (1) (2) (3) ."
2,"In our ternary structure, this water molecule resides 3 Å from the target 2'-OH of the A1 base ribose and remains unperturbed in the ternary structure of SARS-CoV-2 (present study) and binary structures (SAM/SAH-bound) of SARS-CoV-1 8, 14 nsp16."
2,"With this brief note we want to report our experience regarding the management of patients with advanced basal cell carcinoma (BCC) in treatment with the hedgehog pathway inhibitors (HhI) (sonidegib and vismodegib) during COVID-19 period, the preventive measures adopted, and patients' adherence to treatment."
2,"Here, we investigated the efficacy of remdesivir treatment in our recently established rhesus macaque model of SARS-CoV-2 infection."
2,"Additional agents that are under study include emtricitabine/tenofovir and ribavirin (128, 130) ."
4,"Dipyridamole is an FDA-approved drug that our group recently discovered to inhibit NET formation by activation of adenosine A2A receptors (6) ."
4,"his analysis provides a rational dose optimisation for nitazoxanide for treatment and prevention of 341 COVID-19."
0,"However, critically ill cases had more signs of 410 infection and abnormal laboratory findings, including high leukocyte, high procalcitonin, high 411 d-dimer, low albumin, and high creatinine levels."
2,"We undertook a systematic review and meta-analysis investigating IL-6 dysregulation in patients diagnosed with COVID-19, and the potential role of IL-6 suppression with the administration of tocilizumab."
4,"Tocilizumab was approved for the treatment of CRS in 2017."
4,"Tocilizumab and sarilumab are monoclonal antibodies against the IL-6 receptor that are currently being considered for use in patients with COVID-19, who develop cytokine release syndrome (CRS) (20) ."
4,"In early February, Wang et al [3] demonstrated potent in vitro activity of chloroquine against SARS-CoV-2 with an EC50 at 48 hours of 1.13 µM in Vero E6 cells."
2,"The findings from these uncontrolled data will be informed by the ongoing randomized, placebo-controlled trials of remdesivir therapy for Covid-19."
4,"Remdesivir could effectively fight against the new coronavirus"
0," however, ribavirin is invalid."
2,"Patient started oxygen therapy, Hydroxychloroquine and Azithromycin."
2,"This 196 phenomenon is primed by the multifunction serine protease TMPRSS2 20 ."
4,"In conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of COVID-19 and its potential effectiveness in the early reduction of contagiousness."
2,"We incorporated glutamine at the P1 position, because the available crystal structures of SARS-CoV M pro revealed that only glutamine (and, at a very small number of cleavage sites, histidine) residue can occupy the S1 pocket of this enzyme."
2,"However, in a recent report of case-series from critical ill patients in the Seattle region, no cardiac dysfunction was detected by echocardiograms 29 Pneumonia is a highly proinflammatory disease 28 , and elevated levels of cytokines, which included C-reactive protein (CRP), interleukin-6(IL-6), interleukin-8 (IL-8), interleukin-10(IL-10), procalcitonin, interleukin-1beta(IL-1β), Tumor necrosis factor-alpha(TNF-α), Interleukin-10(IL-10), have been detected in COVID-19 patients, especially in ICU patients 19, 33, 34 ."
2,"With the same cohort, we have included readings related to emerging research on the coronavirus, for instance, the RCT on Hydroxychloroquine and Azithromycin was added to the readings and discussion on RCTs and measurement of clinical outcomes."
4,"All surfaces including standard floor, walls, and objects in COVID-19 isolation areas should be disinfected with solutions that have 1000 mg/L chlorine."
2,"Intriguingly, baricitinib inhibits the AP2-associated protein kinase 1 (AAK1) that is a regulator of endocytosis that the SARS-CoV-2 uses to infect lung cells through binding with ACE2."
4,"A small (n=36), non-randomized clinical trial that investigated the use of chloroquine/azithromycin reported that hydroxychloroquine was efficient in clearing viral nasopharyngeal carriages of SARS-CoV-2 in French patients with COVID-19 in only three to six days."
2,"The possibility of under-diagnosis due to muscle pains being a common symptom of COVID-19 as well as creatine kinase (CK) and myoglobin levels not being routinely tested is also highlighted in the letter."
0,"Recent reports of a potential harm with ibuprofen in patients with COVID-19 has received significant international media coverage."
2,"Moreover, 2019-nCoV likely does not use mouse or rat ACE2 as its receptor because mouse or rat ACE2 contains a histidine at the 353 position, which does not fit into the virus-receptor interaction as well as a lysine does (Fig."
0,"Our study suggested that tocilizumab use prior to ventilation in ICU may be optimal since 50% of such cases died, remain ventilated and serious superinfection."
2,"She remained hemodynamically stable and was transitioned to oral anticoagulant therapy (apixaban) with plans to continue anticoagulation for 6 months."
4,"The polymorphism that replaces Y83 with a polar histidine will compromise the hydrophobic character of this unique pocket in addition to removing a polar contact with N487 ( Supplementary Figure 5b) , potentially offering selective protection from the SARS CoV-2 infections."
4,"Also shown are the putative mechanisms of action for bromhexine and hydroxychloroquine in attenuating upstream SARS-CoV-2 tissue binding, the effect of antivirals on replication, azithromycin as an antiviral and immunomudulator, nonspecific cytokine suppression by corticosteroids, together with the selective downstream effect of IL-6 blockade with tocilizumab or sarilumab and effects of anti-TNF and interferon beta-1-a."
4,"In the AMI group, in addition to antiviral and antibiotic therapies, cardioprotective medications such as amiodarone and cedilla were used by four patients to improve the cardiac function."
4,"Chloroquine, an antimalarial, antiamoebic, immunomodulatory, and a potential broad-spectrum antiviral drug, is being reported to be effective in COVID-19."
4,"Moreover, in vitro evidence indicates that TMPRSS2 inhibition by camostat mesylate may be beneficial to prevent the infection of SARS-CoV-2 15 .TMPRSS2 is highly expressed in both localized and metastatic prostate cancers 17, 18 and its transcription is regulated by the androgen receptor (AR) 17 ."
2,"Our simulations go beyond the other models published, indicating that earlier virologic negativization should not be expected when hydroxychloroquine is administered at dosages of 400 mg/day but only at dosages of 600 mg/day, i.e.within the narrow therapeutic window."
4,"Diltiazem is a voltage gated 170 Ca2+ channel antagonist currently used as anti-hypertensive for the control of angina pectoris and cardiac arrhythmia (26) , which we have recently repurposed as an effective host-directed influenza inhibitor due to its so far undescribed capacity of inducing the interferon (IFN) antiviral response, particularly type III IFNs (Fig."
2,"Also, HIV-1 protease bounded to lopinavir under PDB code 1MIU and Bat HKU4 coronavirus PDB code 2YNB were evaluated."
2,"Neutrophil, neutrophil-to-lymphocyte ratio (NLR), fibrinogen, sialic acid (SA), C-reaction protein (CRP), IL-6, interleukin-10 (IL-10) and interferon-γ (IFN-γ) in the severe group were significantly higher than those in the non-severe group (P<0.05).While lymphocyte%, lymphocyte count and platelet count were significantly lower in the severe group when compared with the non-severe group (P<0.05)."
2,"To optimally inform our appraisal of the quality of COVID-19 research, we searched the MEDLINE and EMBASE electronic databases to identify clinical studies on the use of these agents in COVID-19 (2019 to April 3 rd , 2020), finding 564 initial citations that were screened for eligibility, yielding six clinical studies judged eligible (5) (6) (7) (8) (9) (10) .Based on the quality of the evidence to date, can a clinical practice guideline issue any recommendations on the use of chloroquine or hydroxychloroquine alone or combination with other treatments?"
0,"However, a sufficiently powered case-control study has not yet been reported, and thus it is unclear if there are therapeutic benefits of chloroquine administration to SARS-CoV-2-infected patients, although several concerns are being raised recently, due to the severe cardiac complications potentially resulting from the use of this treatment in COVID-19 patients 17, 18 .The repurposing of several approved antiviral therapies have all been the focus of clinical investigations, including HIV-1 protease inhibitors lopinavir/ritonavir (Kaletra, Aluvia by AbbVie) 19 , hepatitis C virus protease inhibitor danoprevir (Ganovo, Ascletis Pharma) 20 , and the influenza antiviral favipiravir (T-705, Avigan) 21 ."
2,"hydroxychloroquine + azithromycin and lopinavir/ritonavir) under investigation and/or in use clinically are known to prolong the QTc and pre-dispose to DI-TdP/DI-SCD ( Table 2) ."
2,"On hospital day 2, painful, irregular contractions began and labor was augmented with oxytocin."
2,"Ribavirin and interferon are also mentioned in the COVID-19 Diagnosis and Treatment Plan; 2 in the present study, four patients in the mild group (7·27%) were administered ribavirin combined with antiviral therapy."
2,"The ReFRAME library has previously been used to successfully identify the anti-inflammatory auranofin as a potential therapy for tuberculosis 29 , the approved drug clofazimine as a potent antiparasitic compound that is now being tested for efficacy against Cryptosporidium 30 , and has also been used to identify and optimize the FDAapproved antifungal drug itraconazole as a novel efficacious molecule suitable for chronic administration as an anti-fibrotic 31 ."
4,"This study meticulously evaluated the various dosages of chloroquine and hydroxychloroquine utilized in clinical trials registered in Chinese and US clinical trial registries for the treatment of pneumonia caused by SARS-CoV-2."
4,"The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease."
4,"AbstractThree anti-HIV drugs, ritonavir, lopinavir and darunavir, might have therapeutic effect on coronavirus disease 2019 (COVID-19)."
4,"Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible). "
2,"Treatments, including antiviral agents, chloroquine and hydroxychloroquine, corticosteroids, antibodies, convalescent plasma transfusion and vaccines, are discussed in this article. "
4,"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. "
2,"This article reviews the influences of cytokine storm syndrome on the COVID-19 and the corresponding immunotherapies to resist cytokine storm. "
2,"Cases of chloroquine-related toxicity have been reported elsewhere, but have not been observed in our hospital so far. "
4,"For this emergency, the FDA has approved Remdesivir and Hydroxychloroquine for treatment of COVID-19 as Emergency Use Authorization."
4,"Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin."
4,"The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease."
0,"Oseltamivir has not been shown to have efficacy, and corticosteroids are currently not recommended."
4,"Seeking to increase supply of Avigan, an influenza drug that may be effective against COVID-19, Fujifilm has signed up two pharmaceutical chemical outsourcing partners. "
4,"Over 200,000 people worldwide could receive the old antimalarial drugs chloroquine and hydroxychloroquine across more than 130 clinical trials designed to treat or prevent COVID-19, according to the US clinical trials database. "
2,"Intravascular fibrin generation has been described during the last decade as an effector of innate immunity: activation of coagulation generates thrombin which drives many amplifications pathways."
2,"The lopinavir and ritonavir are used as a regimen single-agent or combination with either ribavirin or interferon-α."
2,"The same group also published the results of 80 COVID-19 patients receiving a combination of HCQ and azithromycin."
2,"New York 12 ""No pharmacist shall dispense hydroxychloroquine or chloroquine except when written as prescribed for an FDA-approved indication; or as part of a state approved clinical trial related to COVID-19 for a patient who has tested positive for COVID-19, with such test result documented as part of the prescription."
4,"For certain scenarios, next to quarantine, we also inject infected 88 individuals with an antiviral drug (i.e., Remdesivir)."
4,"For ""remdesivir"" a medium Pearson correlation coefficient (r = 0.300, p < 0.05) was found."
4,"One promising example could be remdesivir, which interferes with the viral polymerase and has shown efficacy against MERS in mouse models33."
4,"Many pharmacists were not sure about the role of hydroxychloroquine (12%) and 29% of them thought it has been used as a preventative therapy against the coronavirus infection."
2," isoflavone 360 inside the receptor-binding site of SARS-CoV-2 3CL pro , showing hydrogen bonds with the 361 catalytic dyad (Cys-145 and His-41)."
4,"Remdesivir was also tested for treatment of ebolavirus infections in humans (and found to be less successful than other treatments by Mulangu et al., 2019) ; therefore, safety data exist for this therapeutic agent, which should accelerate the process of clinical testing against SARS-CoV-2."
4,"The efficacy of remdesivir (Gilead Sciences), a nucleotide analog, in inhibiting in vitro and in vivo SARS-CoV-1, MERS-CoV and bat CoV strains that are capable to replicate in human airway epithelial cells render it a good choice for testing on newly affected COVID-19 patients (85,101-103)."
2,"Tocilizumab is a recombinant humanized monoclonal antibody binding to IL6 receptor and inhibiting its signal transduction."
2,"Other drugs that target this subnetwork include Masitinib, Erlotinib, and Sorafenib, which could be further examined in downstream analyses."
2,"Before Coronavirus emergency, our protocol required that patients perform blood test and hospital visit every 4 weeks; after March 8 th 2020 (Prime Minister Decree-law, in Italy), we still had 10 patients in treatment with metronomic vinorelbine."
0,"As can be seen in the two cases, both received lopinavir/ritonavir and hydroxychloroquine but showed persistent fever, rapidly aggravated hypoxemia and progressive bilateral infiltrations in accordance with the criteria of severe ARDS."
0,"A meta-analysis conducted with a total of 6548 patients with influenza pneumonia (H7N9 or H1N1), found the use of systemic GCs (methylprednisolone with different dose ranges, when reported) associated with higher mortality rate (risk ratio [RR] 1.75, 95% confidence interval [CI] 1.30-2.36, Z = 3.71, P = 0.0002), longer intensive care unit permanence and higher rate of secondary infection [44] [45] [46] ."
4,"Clinical studies conducted in COVID-19 patientsIn the positive background of successful in-vitro data and in the situation of an emerging epidemic, the Chinese authorities issued a consensus statement for the use of chloroquine in COVID-19 patients."
2,"One of the findings here suggests that the max number of days per year that Italian provincial capitals can exceed the limits set for PM10 (particulate matter 10 micrometers or less in diameter) or for ozone, considering the meteorological condition has to be less than 50 days."
4,"There are cogent reasons to suggest that a combined treatment modality might be required to obviate upstream SARS-CoV-2 lung tissue binding with hydroxychloroquine or bromhexine, or instead with antivirals, together with downstream IL-6 blockade by sarilumab or tocilizumab (Figure 1 )."
4,"In order to verify whether targeted IL-6, may potentially be the effective and safe way to reduce mortality of COVID-19, 21 patients diagnosed as severe or critical COVID-19 from The First Affiliated Hospital of University of Science and Technology of China and Anhui Fuyang Second People’s Hospital were recruited and given tocilizumab therapy (Table 1)."
4,"This mechanism is the basis of the rationale for the administration of tocilizumab, a monoclonal antibody that inhibits ligand binding to the human interleukin-6 receptor (IL-6R), which was recently approved in China to reduce lung complications in patients with SARS-CoV-2 infection [2] ."
4,"As mentioned above, sofosbuvir is (metabolized to the active drug and) capable of efficient controlling of this type of virus inside the epithelial cells."
4,"Remdesivir works against coronaviruses closely related to SARS-CoV-2 in animal models, as well as against the related MERS-CoV, including in NHPs (Agostini et al., 2018; Brown et al., 2019; de Wit et al., 2020; Sheahan et al., 2017 Sheahan et al., , 2020 ."
0,"Blood biochemistry detection found that several indices related to organ injuries, including lactose dehydrogenase (LDH), aspartate aminotransferase (AST), estimated glomerular filtration rate (eGFR), and sodium ion concentration, were significantly different between grade 3-group COVID-19 patients and non2019-nCoV-infected pneumonia patients."
4,"In many jurisdictions, the laws and regulations are taking ""The joint statement is in response to reports of physicians and others prophylactically prescribing, medications currently identified as potential treatments for COVID-19 (e.g., chloroquine or hydroxychloroquine, azithromycin) for themselves, their families, or their colleagues."
4,"9Multiple prospective, randomized trials of hydroxychloroquine are now underway and will, in due course, provide valuable information about safety and efficacy."
4,"Potential compounds are available for further investigation such as EIDD-2801 (isopropyl ester of N4-hydroxycytidine), Sofosbuvir, IDX-184, Ribavirin and Remidisvir may be considered as its high therapeutic potential in treating emerged viral infection (Wang et al., 2020b, Elfiky, 2020)."
4,"Despite these findings, there has been a study going on to repurpose the utility of sofosbuvir, a ribonucleic acid (RNA)-dependent RNA polymerase inhibitor used in the treatment of hepatitis C along with ribavirin in COVID-19 patients."
4,"The data have shown that 68% of severe patients have relieved symptoms after using remdesivir and the mortality of those patients is 13%, which is noteworthy though these findings need to be confirmed in the ongoing randomized, placebo-controlled trials of remdesivir therapy for COVID-19 [9] ."
4,"Nevertheless, the United States Food and Drug Administration used its emergency authority for only the second time ever to permit the use of a drug for an unapproved indication 8 in the case of hydroxychloroquine for Covid-19 in situations where clinical trials are unavailable or infeasible."
0,"Furthermore, the efficacy of hydroxychloroquine has not been thoroughly established for COVID-19 # using simple linear regression, $ using multiple linear regression, * significant at 0.05 significance level."
2,"Ibuprofen and thiazolidinediones have also been shown to do the same viii,ix ."
4,"Based on work conducted in our lab, we recommend the concomitant use of low dose hydroxychloroquine with an anti-inflammatory drug to help mitigate the cytokine storm in critically ill SARS-CoV-2 patients."
4,"However, oxidative agents containing mouth rinses with 1% hydrogen peroxide or 0.2% povidone-iodine are recommended."
4,"Among these inhibitors tested, the high concentrations of drugs were required to inhibit SARS-CoV-2 replication in amprenavir (EC 50 = 31.32 µM, CC 50 > 81 µM, SI > 2.59), darunavir (EC 50 = 46.41 µM, CC 50 > 81 µM, SI > 1.75), and indinavir (EC 50 = 59.14 µM CC 50 > 81 µM, SI > 1.37) (Fig."
4,"Of course, it is too early to conclude the direct antiviral effect of remdesivir on enhanced clearing of viral loads in the respiratory tract, but it indeed suggests a promising therapeutic effect of remdesivir."
2,"Therefore, repurpose of existing antiviral agents including interferon, chloroquine (an antimalarial agent) and niclosamide (a broad spectrum anthelminthic) have attracted considerable attention and many trials are underway (4, 5) ."
2,"Also, due to the existence of an amino acid proline in the polybasic cleavage site, which makes the inserted sequence PRRA, there are three O-linked glycans introduced to the 2019-nCoV RBD residues S673, T678, and S686 (7).SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2 When compared to SARS-CoV S B , the motif binding the human ACE2 to the SARS-CoV 2 S B showed a relatively higher binding affinity for human ACE2 as indicated in smaller equilibrium dissociation constant (2.9 nM vs. 7.7 nM) (3) ."
4,"Interestingly chloroquine has been shown to be effective in reduction of viral replications including COVID-19."
4,"Panel A shows viral loads andPanel B shows infectious virus titers in BAL collected from rhesus macaques infected with SARS-CoV-2 and treated with remdesivir (red circles) or vehicle solution (black squares)."
2,"All of them had data on plasma AngII, renin and aldosterone in the lying position without sodium restriction."
0,"Smokers Are Living on the EdgeThe likeliness of COVID-19 patients to contract neurological infections can beexacerbated by secondary factors like smoking, which according to a pilotstudy can enhance the chances of contracting COVID-19 based neuroinfectionsdue to the functional interactions between hACE2 and the nicotinic receptor(nAChR).8 The same study reports that due to thecoexpression of hACE2 and nicotinic acetylcholine receptor (nAChR) in manycells, there exists a functional link between them."
2,"In this context, there is an ongoing worldwide debate regarding the use of angiotensinconverting enzyme (ACE) inhibitors and ibuprofen in patients with COVID-19."
0,"However, toxicities are substantial including severe cytopenias, hepatotoxicity (including fatality), neuropsychiatric events, and risk of developing fatal or life-threatening ischemia or infection, particularly when combined with ribavirin."
0,"ibuprofen could worsen COVID-19 symptoms, despite the fact that there is currently no scientific evidence to support this claim."
4,"TKIs could be tried as further options: in different models of inflammations, Bosutinib showed optimal anti-inflammatory properties, already demonstrated by its ability of reverting the pro-inflammatory effects of Dasatinib."
4,"On the basis of these investigations, we believe that hydroxychloroquine can be effective in preventing respiratory tract invasion in HCWs exposed to SARS-CoV-2 and that hydroxychloroquine administration as a prophylactic agent could be particularly useful for HCWs attending to high-risk procedures on the respiratory tract in COVID-19 patients."
4,"It is thought to cause local inflammation, and it is expected that the antiviral and anti-inflammatory effects of ciclesonide will be effective in treating lung injury caused by coronavirus, which is becoming more severe."
4,"COVID-19 THERAPY Nafamostat is a synthetic serine protease inhibitor and a potent inhibitor of MERS CoV."
4,"suggests that tocilizumab is an important therapy in serious COVID-19 patients, which offered a new therapeutic approach to this deadly infectious disease79."
4,"In China and South Korea lopinavir 200 mg/ritonavir 50 mg has already been used for the treatment of COVID-19."
2,"In 2019-nCoV nsp12, the 2' hydroxyl of the incoming NTP is likely to form hydrogen bonds with T680 and N691 in motif B (Figs."
4,"There is also data suggesting that statins might enhance angiotensin converting enzyme 2 (ACE2), which could mitigate the invasion of SARS-CoV-2 through the ACE2 receptor, potentially having a beneficial effect in attenuating risk of infection [18] ; another data, based on in-silico study, showed that pitavastatin, rosuvastatin, lovastatin, and fluvastatin could be efficient SARS-CoV-2 main protease inhibitors [19] ."
0,"According to the results of our study, higher temperature, blood leukocyte count, neutrophil count, neutrophil percentage, C-reactive protein level, D-dimer level, alanine aminotransferase activity, aspartate aminotransferase activity, α - hydroxybutyrate dehydrogenase activity, lactate dehydrogenase activity and creatine kinase activity were related to severe 2019 novel coronavirus pneumonia and composite endpoint, and so were lower lymphocyte count, lymphocyte percentage and total protein level."
2,"It is noteworthy that even pharmaceutical-grade heparin preparations remain a polydisperse mixture of natural products, containing both anticoagulant and nonanticoagulant saccharide structures."
4,"It is of interest that clearance of CMV is enhanced when IBD therapy is added to ganciclovir 32 and that thiopurines and cyclosporine may have anti-coronavirus properties."
2,"The mechanism for intestinal perforation in patients receiving tocilizumab is not fully understood, but prior diverticulitis has been noted as a risk factor [2] ."
4,"At this time, more than ever, the high-quality, robust, comparative evidence from ethical randomized controlled trials (RCTs) is urgently needed to assess patient-important outcomes, including mortality, morbidity, need for life support, safety, and toxicity, informing on the safe use of chloroquine or hydroxychloroquine (with and without azithromycin) in people with COVID-19."
2,"The human host receptor of SARS-CoV-2 is angiotensin-converting enzyme 2 (ACE2), which is highly expressed in the intestines [3] ."
2,"The other atoms of lepidine E forms hydrogen bond with 2019-nCoV protease residues, whereas, NH of both imidazole rings bind to Oxygen atom (of main chain) of Thr24and His164 (with interatomic distances ""ID"" of 2.32 and 2.38Å)."
2,"The Arginine (R) in the conserved motif KRSFIEDLLFNKV that was of interest in the previous study [2] is the cleavage point in S2'.Recall that the KRSFIEDLLFNKV subsequence associated with S2' is potentially important, not least because it must be exposed or exposable (because it permits proteolytic cleavage) and therefore the site cannot be well shielded."
4,"It was strengthened by evidence that remdesivir was successful in both preventing and controlling MERS-CoV-induced clinical disease in nonhuman primates [33]."
4,"Arbidol, a small indole derivative molecule, was found to block viral fusion against influenza A and B viruses and hepatitis C viruses [48] and confirmed to have antiviral effect on SARS-CoV in cell experiment [49] , so that it might be a choice for COVID-19 treatment."
2,"It is an adenosine analogue, which incorporates into nascent viral RNA chains and results in premature termination."
4,"In contrast to the above findings with SARS-CoV, hydroxychloroquine was found to be more potent against SARS-CoV-2 [39]."
2,"This result indicates that serum urea, CREA, and CysC could be used as potential biochemical biomarkers to identify a severe COVID-19 patient."
4,"Although we mainly conducted in vitro assays to experimentally validate the anti-SARS-CoV-2 effects of olaparib and CVL218 due to limited time, it is natural to speculate that other PARP1 inhibitors may also have antiviral activities against SARS-CoV-2 infection, based on our computational prediction and experimental validation results."
0,"However, to date, there is no clinical evidence to support the use of hydroxychloroquine as a treatment for SARS-CoV-2 infection."
4,"Thalidomide has an anti-inflammatory action due to its ability to speed up the degradation of messenger RNA in blood cells and thus reduce tumor necrosis factor-α (TNFα)."
4,"In our opinion, this pro-atherogenic aspect might made Nilotinib a sub-optimal candidate in the COVID-19 context."
2,"SARS-CoV and SARS-CoV-2 use angiotensin converting enzyme 2 (ACE2), while MERS-CoV uses CD26 as a receptor; 2) S2 is cleaved by a cell surface transmembrane protease, serine 2 (TMPRSS2), so-called priming, which exposes the fusion peptide in S2 protein, allowing it to attach to the plasma membrane resulting in the fusion between envelope and the plasma membrane (envelope fusion)."
4,"16.20067405 doi: medRxiv preprint nitrogen oxides have an effect on COVID-19 related cases and death while ozone only has an effect on COVID-19 deaths."
0,"At the time of designing this study, it was said that NSAIDs such as ibuprofen can increase the risk of complications when used during viral infections (including the coronavirus infection)."
0,"Continuous renal replacement therapy and heparin exposure induce critical thrombocytopenia"
2,"The concentration of teicoplanin required to inhibit 50% of viruses (IC 50 ) in vitro was 1.66 μM, which is much lower than the concentration reached in human blood (8.78 μM for a daily dose of 400 mg) [7] ."
2,"Similarly, the mean level of lactate dehydrogenase level detected in the blood of children infected with SARS-CoV-2 (315.75U/L) was elevated relative to the recommended reference range for children aged 1 to 10 years (<305U/L) 48 ."
2,"This study was specifically conducted to examine the various dosages of chloroquine and hydroxychloroquine utilized in previous clinical trials registered and underwent for the treatment of pneumonia caused by SARS-CoV-2."
4,"medRxiv preprint aerosol and the digestive tract of transmission is unclear, the general population susceptibility, the novel coronavirus is sensitive to ultraviolet light and heat, most disinfectants can effectively killed virus"
2,"Their treatment included Methylprednisolone 40 mg daily intravenous (IV) injections for one and five days for the male and the female patient respectively, human gamma globulin 10g IV qd for five and seven successive days for the male and the female patient, respectively, and then the dose was changed to 5g for both of them, in addition to Moxifloxacin, Oseltamivir, Arbidol hydrochloride, and Tanreqing (Chinese patent medicine)."
4,"Furthermore, this study strongly supports the repurposing of heparin and its derivatives as antiviral agents, providing a rapid countermeasure against the current SARS-CoV-2 outbreak."
2,"Recently, we demonstrated that COVID-19 severity in adult patients was strongly associated with higher interleukin-6 (IL-6) levels."
4,"For critically ill adults with COVID-19 who develop fever, acetaminophen might be a better choice for temperature control than NSAIDs."
4,"In conclusion, early, low-dose and short-term application of methylprednisolone was associated with better clinical outcomes in severe patients with COVID-19 pneumonia, and should be considered before the occurrence of ARDS."
4,"Conclusions With an effective reduction of pulmonary viral load in a murine model of SARS-CoV infection, potent antiviral activity against SARS-CoV-2, acceptable safety profile of parenteral remdesivir therapy in two case reports, and a randomised trial of Ebola virus disease, the clinical use of remdesivir in the cases of COVID-19 is are highly anticipated."
0,"The simultaneous exposure to air pollutants such as particulate matter (PM) and Nitrogen dioxide (NO2) alongside COVID-19 virus is expected to exacerbate the level of COVID-19 infection and risk of fatality [9, 10] ."
2,"The viral cDNA was used as input for multiple overlapping PCR reactions (~2.5kb each) spanning the viral genome using Platinum SuperFi master mix (primers provided in Supplementary Table S1 )."
4,"A recent study demonstrates in cell culture experiments with simian Vero E6 cells infected with SARS-CoV-2 that remdesivir is inhibitive against SARS-CoV-2 infection at EC90 of 1.76 µM, a concentration achieved in vivo in nonhuman primate models [36] ."
0,"Although currently there are noapproved antiviral drugs for the treatment of human coronavirus infections available,preclinical data with the nucleotide analog remdesivir (RDV) are promising, and human safetydata are available (1)."
0,"However, no apparent activity of oseltamivir and zanamivir was previously observed against SARS-CoV-1 in vitro [28] , and the fact that up to 76% of the first critically ill patients with COVID-19 received oseltamivir may also be related to the suspicion of infection (or co-infection) with influenza [29] ."
0,"Moreover, the effects of abidol, oseltamivir, or methylprednisolone in SARS-CoV-2 infection have not been fully evaluated."
4,"Successful cases of remdesivir in treating COVID-19Presently, there have been successful cases of remdesivir in the treating COVID-19."
4,"Recently, tocilizumab a monoclonal antibody that competitively inhibits the binding of IL-6 to its receptor has been used to treat complications of COVID-19 induced pneumonia and China's National Health Commission and the Italian Medicines Agency approved the tocilizumab use in severe patients with extensive lung disease and with elevated IL-6 levels detected by the laboratory."
4,"Molecular docking studies of RNA dependent RNA polymerase model suggest that Sofosbuvir in combination with Ribavirin and Remidisvir could exhibit possible therapeutic effects in SARS-CoV-2 (92)."
0,"Furthermore, there is no evidence supporting claims that ether and chloroform inhalation is useful in the treatment of COVID-19."
2,"There are several anakinra studies registered for COVID-19, testing 100 mg daily subcutaneous injection for 28 days to 400–600 mg/day intravenous for 5–7 days (NCT04339712, NCT04330638)."
2,"Overall, nearly 9.4% of critically ill patients admitted to the ICU with SARS-CoV-2 (55 out of 585 patients) had AKI; these results are summarized in Table 3.Taken together, these findings indicate that kidney function should be closely monitored when treating patients with COVID-19, particularly patients with preexisting CKD and/or abnormal serum creatinine levels, blood urea nitrogen levels, or relevant CT findings [22]."
0,"100 per cent of inhibition of coronavirus replication is not reachable experimentally using hydroxychloroquine."
0,"but chlorine has not effectively inactivated virus, should avoid to use hand disinfectant containing chlorine has set."
0,"the number of sudden cardiac deaths reported with potential COVID-19 treatments are, respectively, 81 and 105 for hydroxychloroquine, 26 and 48 for lopinovir/ritonavir, 54 and 151 for imatinib and 27 and 251 for azithromycin."
4,"Chloroquine was found to be efficient on SARS-CoV-2 [18, 19] ."
4,"Several antiviral therapies have been considered to be potentially effective in treating COVID-19, including oseltamivir, ganciclovir, arbidol and lopinavir / ritonavir."
0,"There are no data currently about the use of remifentanil PCA in obstetric patients with COVID-19 infection."
4,"Twenty out of 21 pregnant patients used ribavirin as the antiviral for the treatment of COVID-19."
0,"there's no evidence to suggest that using ibuprofen to manage symptoms of COVID-19 will worsen the condition"
0,"Furthermore, there is no evidence supporting claims that ether and chloroform inhalation is useful in the treatment of COVID-19."
0,"In summary, despite a reported antiviral activity of chloroquine against COVID-19 in vitro, we found no evidence of a strong antiviral activity or clinical benefit of the combination of hydroxychloroquine and azithromycin for the treatment of our hospitalised patients with severe COVID-19."
4,"It is noted that lopinavir wasobserved to be effective in treating COVID-19 patients."
0,"Although prior treatment with LPV/r failed to improve oxygenation, treatment with ciclesonide coincided with a positive outcome."
0,"also showed that oseltamivir and baloxavir failed to inhibit SARS-CoV-2 in vitro 11 ."
4,"Arbidol, an indole-derivative, has been licensed for decades in Russia and China against influenza."
0,"This may explain why baloxavir failed to block SARS-CoV-2 infection"
0,"Of note, other HIV-1 reverse transcriptase inhibitors such as Tenofovir, Emtricitabine and their combination also failed to show any antiviral effect against SARS-CoV-2"
0,"combination lopinavir and ritonavir recently failed in a clinical trial for COVID-19 with no significant therapeutic efficacy was observed"
0,"There is no evidence that eating garlic has protected people from the new coronavirus"
0,"No evidence on the efficacy of anti-diarrheal drugs is available"
0,"It is noteworthy that the latest study found no evidence of clinical benefit of the combination of hydroxychloroquine and azithromycin for the treatment of 11 patients with severe COVID-19"
0,"Investigators concluded that there is no evidence of a strong antiviral activity or clinical benefit of the combination of HCQ and azithromycin for the treatment of hospitalized patients with severe COVID-19"
0,"Furthermore, there is no evidence supporting claims that ether and chloroform inhalation is useful in the treatment of COVID-19"
0,"Remdesivir is an investigational agent not commercially available, safety and efficacy have not been established in COVID-19 patients."
4,"During the current COVID-19 pandemic, there has been increased interest in using off-label medications for treatment of the novel coronavirus (SARS-CoV-2), including drugs with a propensity for QT prolongation such as hydroxychloroquine and azithromycin."
4,"Additionally, The janus kinase inhibitor baricitinib, which can disrupt receptor mediated endocytosis and interrupt the passage of the virus into cells, was identified to reduce the ability of the virus to infect lung cells and be a potential treatment for 2019-nCoV.35In addition to the therapeutics discussed above, Chinese healthcare practitioners also have started clinical trails of stem cell infusion and traditional Chinese medicine for severe patients."
0,"One group reported no significant difference in time to viral clearance between patients who received methylprednisolone orally (mild disease) or IV (severe) and those who did not ."
2,"In addition, the carbonyl group of baicalein is hydrogen bonded with the backbone amide group of E166."
4,"IntroductionChloroquine, and its hydroxy-analog hydroxychloroquine, was first proposed in 2003 for treatment of the severe acute respiratory syndrome (SARS) [1] and, due to its promising in-vitro effects [2] , was then repurposed as a drug for treatment of COVID-19."
2,"This observation could be explained by the types of calcium channels that each drug blocks; benidipine hydrochloride blocks triple voltage-gated calcium channel inhibitor, whereas lercanidipine hydrochloride blocks single voltage-gated channel (Klein and Köppel H, 1999; Ozawa et al., 2006; Wirtz and Herzig, 2004) .Together, we identified 12 FDA-approved drugs that could be considered for repositioning to MERS-CoV or COVID-19 therapy."
2,"Specifically, the levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) on admission were higher in ECMO treated patients (median AST 38."
4,"Colson group have suggested that chloroquine and hydroxychloroquine as available weapons to fight COVID-19 (Colson et al., 2020)."
2,"These are Chloroquine phosphate and hydroxychloroquine sulphate (also known as anti-malarial drugs), arbidol, Remdesivir (GS-5734), Favipitavir and ribavirin (a complex structure but best viewed as ribosyl purine analogues)."
4,"The combined use of Arbidol and Oseltamivir appears to be able to further is associated with a reduction in the mortality."
0,"Concurrent use of azithromycin with hydroxychloroquine for treating COVID-19 is not routinely recommended."
2,"Sarilumab an inhibitor of soluble and membrane IL-6Rα receptors may reduce the severity of the pulmonary complications of COVID-19, including respiratory failure, but there is no evidence that it has anti-viral potential."
4,"aprotinin or camostat) and antivirals provides a 537 promising approach to block SARS-CoV-2 replication that should be tested in cell cultures 538 and animal models and should furthermore be considered as therapeutic strategy for the 539 treatment of COVID-19."
2,"Regarding antiviral interventions, 7 patients received compassionate-use remdesivir, but we have insufficient information to report associated outcomes."
4,"The virus is susceptible to many active ingredients (AI), such as sodium hypochlorite (0.1%–0.5%), 70% ethyl alcohol, povidone-iodine (1% iodine), chloroxylenol (0.24%), 50% isopropanol, 0.05% benzalkonium chloride, 1% cresol soap, or hydrogen peroxide (0.5%–7.0%), etc."
4,"Chloroquine was used as a positive control 37, 38 .Remarkably, at concentration 100 nmol/L, DIP suppressed more than 50% of SARS-CoV-2 replication (Fig."
4,"This is in part because a large study screening existing FDA approved drugs for repurposing as antiviral therapeutics reported three different immunosuppressive agents widely used in transplant recipients-tacrolimus, mycophenolate, and sirolimus-as potential therapies for Covid-19 [1] ."
4,"Certain biologics, notably tocilizumab, an anti-interleukin (IL)-6R antibody, may have some efficacy to prevent death."
4,"HCQ in dose of 200mg three times daily was given to 20 patients for 10 days, additionally six patients in this group received azithromycin (500 mg on day 1, 250mg on days 2-5) to prevent bacterial superinfection."
0,"Nitrogen dioxide may contribute to both diabetes pathogenesis and COVID-19 mortality."
4,"The antiviral drug remdesivir (RDV) can inhibit the growth of COVID-19 and found to be efficacious in the clinic in combination."
0,"As spills are inevitable, surfaces should be cleaned rapidly by using appropriate absorbent and by decontamination with chlorine (5000-10 000 mg/l) or another appropriate disinfectant (note that chlorhexidine is ineffective against COVID-19 and is not appropriate) [12] ."
4,"Specifically, in addition to the Ritonavir, it surprisingly outputs Remdesivir with high confidence, which is a star candidate for COVID19 by blocking the RNA polymerase and has shown initial clinical effects 16 ."
4,"In vitro drug testing has shown the antimalarial hydroxychloroquine to have antiviral activity against SARS-CoV-2 and could be potentially used as chemoprophylaxis for healthcare workers."
2,"The trypsin-like serine protease hepsin which has a fairly broad action and which is significantly inhibited by a diverse set of ligands, a particular example of one such binding is represented by protein data bank entry 5ce1."
4,"Noteworthy, the author would like to stress that on the 9 th of March, 2020, nitazoxanide was previously suggested, among other drugs, by French colleagues to be evaluated for its potential against SARS CoV-2; unfortunately, their recommendation wasn't popular and has been practically ignored 22 ."
2,"More specific to coronaviruses, SARS-CoV-1 was shown to upregulate hfgl2 prothrombinase gene, which may further contribute to thrombin generation and hypercoagulable state in COVID-19 [45]."
2,"Several studies have shown that lower total cholesterol level may be related in part due to lower Cu level in adults [21, 30, 31] ."
2,"SARS-CoV-2 primarily relies on the serine protease TMPRSS2 but can also utilize an alternate pathway involving Cathepsin B/L in TMPRSS2-negative cells 6 ."
4,"Chloroquine is a 9-aminoquinoline that was synthesized in 1934 as an effective substitute for natural quinine used against malaria (Figure 7 ) [89] [90] [91] ."
4,"Tofacitinib and Ruxolitinib are both known to inhibit Janus kinase (Jak), which promote cytokine signaling 14, 15 ."
0,"In this context, our observations evidence that optimal Covid-19 infection management with tocilizumab is not achieved during hyperglycemia both in diabetic and non-diabetic patients."
2,"A first step would be to repeat the in vitro study reported by Caly, Druce (1) with other compounds that could theoretically potentiate ivermectin's inhibition of SARS-COV-2 to ."
2,"with nivolumab, a PD-1 checkpoint inhibitor, without adverse event and with a hold partial response."
2,"In the docking model, baicalein binds well in the substrate binding site of SARS-CoV-2 3CL pro with its 6-OH and 7-OH forming hydrogen bond interactions with the carbonyl group of L141 and the backbone amide group of G143, respectively ( Figure 2A )."
2,"Since the combination of lopinavir and ritonavir was already available in the local hospital, a randomized controlled trial was initiated quickly to assess the efficacy and safety of combined use of lopinavir and ritonavir in patients hospitalized with COVID-19 infection."
4,"Visits for new evaluation of chronic urticaria can be postponed, with referring physicians given instructions to start the patient on every-day-twice-a-day dosing of potent nonsedating antihistamines (eg, cetirizine, fexofenadine, or loratadine), according to best evidence, pending resolution of the COVID-19 pandemic."
0,"On a similar note, there is some suggestion that ibuprofen may increase expression of ACE-2 receptor, potentially increasing binding of the virus to target cells and potentiating the SARS-CoV-2 infection."
4,"Suggested dosing regimens for hydroxychloroquine to treat SARS-CoV-2 infectionThe free lung trough concentrations were also projected from the simulations."
4,"Otherwise, Lanjuan Li, infectious disease scientist, academician of Chinese Academy of Engineering, recommended darunavir (CAS#: 206361-99-1), also an HIV protease inhibitor, as a treatment for COVID-19."
4,"It suggests that chloroquine's binding to Covid-19 proteins will follow the same patterns of attachment to both hydrophobic and thermodynamically active residues."
4,"Three combinations were deemed effective: sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin, all of which consisting of at least one anti-cancer agent (an immunosuppressant, an antineoplastic agent and a selective estrogen receptor modulator respectively) (11) .Amidst this rapid evolution of the COVID-19 should be kept in mind the need to respect some clinical research ethics."
0,"The existence of hydroxychloroquine failure in two patients (mother and son) is more suggestive of the last mechanism of resistance."
4,"We therefore recommend that COVID-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of COVID-19 in the world."
4,"Following the SARS outbreak, existing antivirals, including nine protease inhibitors [3] , nelfinavir blocked SARS-CoV-2 replication at lowest concentration (EC 50 = 1.13 µM, CC 50 = 24.32 µM, SI = 21.52)."
2,"In due course, more individual-level data will emerge, and the association between the severity of COVID-19 and many factors, including selenium, can be explored."
2,"Currently, several drugs such as remdesivir, hydroxychloroquine, chloroquine, Ritonavir+Lopinavir, Arbidol and interferon are undergoing randomized controlled trials (RCTs) to test their efficacy and safety for the treatment of COVID-19 in many countries [13] [14] [15] [16] [17] [18] ."
4,"From a recent study of compassionate-use remdesivir, a clinical improvement was observed in 36 of 53 patients (68%)."
2,"Remdesivir is a monophosphoramidate prodrug of an adenine nucleotide analogue."
2,"After the procedure is completed, discuss with the admitting team and draw blood tests from the sheath that may be necessary for COVID-19 and stroke workup if not already done (ie, arterial blood gas, complete blood count, Chem 7, creatine kinase, and hypercoagulable panel in younger patients, B-type natriuretic peptide, troponin, hemoglobin A1c, cholesterol panel, etc) to limit the need for additional blood draws and exposures."
4,"In 2014-2017, ivermectin antiviral drug used for phase 3 treatment of dengue infection, daily oral dose significantly reduced in serum level of viral NS1 protein."
2,"This particularly applies to renin-angiotensin system (RAS) blockers and the non-steroid anti-inflammatory drug (NSAID) ibuprofen, and is based on the idea that these drugs upregulate the expression of Angiotensin-Converting Enzyme (ACE) 2, the receptor which facilitates SARS-CoV-2 entry [3]."
2,"Thus, based on our analysis of the biological pathways of hepatitis C and coronaviruses, the molecular structures and activities of viral inhibitors, model polymerase and SARS-CoV RdRp extension experiments described below, and the efficacy of Sofosbuvir in inhibiting the HCV RdRp, we expect that Sofosbuvir or its modified forms should also inhibit the SARS-CoV-2 polymerase."
4,"Combination therapy with 2019-nCoV specific monoclonal antibodies and remdesivir can be considered as the ideal therapeutic option for 2019-nCoV (Cohen 2020)."
2,"preprint HIV-1 and coronavirus IBV replication 54,55 , and the double-stranded RNA-specific editases 387 ADAR and ADARB1, which catalyse the hydrolytic deamination of adenosine to inosine 49 The idea that SARS-CoV-2 sequesters different elements of the transcriptional machinery is 408 particularly intriguing and is supported by the fact that a large number of proteins identified in our 409 screening are found in stress granules 63 ."
4,"Other countries affected by this pandemic like South Korea and China have drafted guidelines for the use of HCQ and chloroquine for therapeutic treatment of COVID-19"
2,"Since the combination of lopinavir and ritonavir was already available in the designated hospital, a randomised controlled trial has been initiated quickly to assess the efficacy and safety of combined use of lopinavir and ritonavir in patients hospitalised with 2019-nCoV infection."
4,"A retrospective cohort analysis of 201 patients from Wuhan suggested that methylprednisolone might benefit patients who develop ARDS (n=88) by reducing the death rate."
4,"They can be used either alone or in combination with polymerase inhibitors such as remdesivir as a means to achieve potential synergic antiviral effect as well as to suppress drug resistance."
4,"According to articles published in Nature Communications and Nature reviews drug discovery (Sheahan et al, 2020 and Guangdi et al, 2020) [48, 49] , currently, only four drugs (Ritonavir, Darunavir, cobicistat, and ASC09F) are considered for treatment of 2019-nCoV as 3CLpro inhibitors."
4,"Existing drugs that can potentially treat COVID-19 (repurposing)remdesivir, lopinavir and ritonavir in combination; lopinavir/ ritonavir plus interferon-beta; and chloroquine and hydroxychloroquine"
2,"We found 18 clinical trials evaluating hydroxychloroquine or chloroquine, whose mechanism of action is similar."
2,"Given its questionable efficacy in the treatment of COVID-19 and its risk of QT-prolongation, chloroquine treatment must be considered thoroughly, and reviewed on a regular basis."
4,"Current guidelines [26] recommend IFN-alpha, lopinavir/ritonavir, ribavirin, chloroquine phosphate, and arbidol as antiviral therapies."
2,"For instance, significant QT prolongations may result from combinations of hydroxychloroquine and haloperidol."
2,"direct IL-6-mediated blockade of hERG/K v 11.1 potassium channels), ii) cardiac sympathetic nervous system hyperactivity, and iii) inhibition of cytochrome P450 enzymes involved in the metabolism of some QTc-prolonging drugs (e.g."
2,"Predicted heparin binding domains in SARS-CoV-2 S1 RBD (330-583)."
2,"A clinical double-blind, randomized, placebo-controlled trial (NCT04303507) will be initiated in may 2020 to evaluate the potential prevention of COVID-19 by chloroquine at a loading dose of 10 mg base / kg, followed by 150 mg of chloroquine base (250 mg chloroquine phosphate salt) daily for 3 months in 10 000 healthcare workers or other individuals at significant risk."
2,"A large number of therapeutic measures such as low-dose methylprednisolone, chloroquine phosphate, hydroxychloroquine, ribavirin, angiotensin receptor 2 blockers, anti-ageing drugs such as azithromycin, quercetin, rapamycin and doxycycline, IL-1 or IL-1R suppressors, protease inhibitors such as lopinavir/ritonavir, acetazolamide, nifedipine, phosphodiesterase inhibitors, convalescent plasma transfusions, tocilizumab, traditional Chinese medicine, statins, zinc supplements, and therapeutic neutralizing and monoclonal antibodies have been either tried or suggested for patients with COVID-19 over a short span of about 4 months in the desperate hope of an effective treatment of these patients (3) ."
2,"The oxygen atom of the aldehyde group also plays a crucial role in stabilizing the conformations of the inhibitor by forming a 2.9-Å hydrogen bond with the backbone of residues Cys145 in the S1′ site."
0,"Data from the 2002-2003 outbreak indicate that SARS may be associated with lymphopenia, leukopenia, and thrombocytopenia, elevated levels of LDH, alanine transaminase (ALT), AST, and creatine kinase [54, 55] , but also, and not significantly seen, nor consistently reported, in COVID-19 studies and cases, with thrombocytopenia, mild hyponatremia, and hypokalemia."
2,"This is the case for the broad-spectrum macrocyclic lactone ivermectin, as reported by based on their data showing that ivermectin inhibits the replication of SARS-CoV-2 in vitro."
4,"The broad-spectrum antiviral agent ribavirin [8] , protease inhibitor lopinavir and ritonavir [9, 10] and immune up-regulator interferon [11, 12] were most commonly used."
2,"The effectiveness of other medicines and regimens such as Chloroquine, Vitamin C, and Chinese medicine, as well as Lopinavir/Ritonavir combination therapy and Remedesevir are being evaluated in China."
4,"Therefore, some authors have suggested that interfering of IL-6 might be a potentially beneficial for severe and critical COVID-19 [2]"
2,"The available monoclonal antibody therapies (anti-tumor necrosis factor (TNF) therapies, ustekinumab, or vedolizumab) should have their dosing delayed for 2 weeks while monitoring for development of COVID-19."
2,"He developed AKI with serum creatinine 967 mmol/l and eGFR 5 ml/min per 1.73 m 2 (baseline creatinine: 400-450; baseline eGFR: 12-16)."
2,"Recently, human Transmembrane Protease Serine 2 (TMPRSS2) has been shown to carry out the priming of the SARS-CoV-2 spike protein by generating two distinct fragments of the viral spike protein, S1/S2 and S2' (Hoffman et al.,###2020)."
4,"Hence, it is necessary to consider hydroxychloroquine instead of chloroquine when the latter is not available for treating patients with COVID-19."
2,"We found higher leptin levels in SARS-CoV-2 ventilated"
2,"Clinical trials on promising regimens for COVID-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the COVID-19 epidemic 12 "
0,"Remdesivir is not approved to treat any condition by regulatory agencies, including the US FDA or the European Medicines Agency."
4,"Moreover, in vitro studies have demonstrated that mycophenolic acid has activity against other coronaviruses, namely MERS-CoV [2] ."
4,"Due to lack of an effective alternative drugs for treating sick patients in intensive care set up, especially with co-morbidities like diabetes, hypertension, coronary artery disease and immunocompromized status, various drug regulatory authorities have allowed the use of HCQ."
2,"A further study was undertaken, in which the RNA-dependent polymerase (RdRp) of SARS-CoV-2 was modelled, validated and then targeted using anti-polymerase drugs currently registered for use against various viruses (Ribavirin, Remdesivir, Sofosbuvir, Galidesivir and Tenofovir)."
2,"All the trials were filtered out based on the presence of word ""chloroquine"" in the title irrespective of the chemical forms of the molecule (hydroxychloroquine) or trials being carried alone or in combination with other antivira therapies."
4,"For instance, heparin was administered as part of standard of care at Mount Sinai as of April 10, 2020 due to the negative impact of SARS-CoV-2 on coagulation and consequent professional recommendations 19 ."
2,"On 18 February 2020, a 74-year-old Chinese woman with COVID-19 in Thailand was treated at Rajvitjhi Hospital for COVID-19-related pneumonia with a cocktail of HIV and flu drugs [32]."
0,"It thus seems likely that the rapid control of the pulmonary hyperinflammation resulted from tocilizumab treatment."
0,"However, attention should be paid to the potential detrimental effects of chloroquine observed in previous attempts to treat viral diseases."
2,"Crystals were grown from a solution containing 10 mmol/L sodium acetate, 50 mmol/L sodium cacodylate (pH 6."
4,"To summarize the abovementioned data, we can say that IDX-184, Sofosbuvir, and Ribavirin can tightly bind to the newly emerged coronavirus RdRp and hence contradict the function of the protein leading to viral eradication."
4,"By using a physiologically-based pharmacokinetic model for chloroquine phosphate and hydroxychloroquine in human lung fluid, it was demonstrated that the concentrations of hydroxychloroquine recommended for treatment of SARS-CoV-2 infection comprise an oral loading dose of 400 mg twice daily at day 1, followed by an oral maintenance dose of 200 mg twice daily for 4 J o u r n a l P r e -p r o o f days [47] ."
4,"Low-dose prednisolone and tacrolimus therapy may have beneficial impacts on the course of SARS-CoV-2."
4,"Although data from several ongoing randomized, controlled trials will soon provide more informative evidence regarding the safety and efficacy of remdesivir for Covid-19, the outcomes observed in this compassionate-use program are the best currently available data."
2,"This steroid is known to cause fluid retention, electrolyte derangement, and hypertension as direct CV effects, and it also may interact with warfarin via an undescribed mechanism."
4,"Remdesivir has broadspectrum activity against members of several virus families, including filoviruses (e.g., Ebola) and coronaviruses [e.g., SARS-CoV and Middle East respiratory syndrome coronavirus (MERSCoV)] and has shown prophylactic and therapeutic efficacy in nonclinical models of these coronaviruses."
4,"Several clinical trials are underway to provide real-world clinical data on the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19 (Supplemental Table) ."
2,"reported that SARS-CoV-2 and SARS-CoV share a common receptor angiotensin-converting enzyme 2 (ACE2) that is required to enter target cells, and cellular protease transmembrane protease serine 2 (TMPRSS2) can cleave and activate the spike protein of SARS-CoV-2 for membrane fusion 4 ."
4,"Validation studies further confirmed 30 known drugs to inhibit viral replication, including four molecules previously approved by the FDA (clofazimine, acitretin, tretinoin, and astemizole) or registered outside the US (tamibarotene)."
2,"Fourth, we were unable to assess hormone profiles in our cohort, including total testosterone, luteinizing hormone, and follicle stimulating hormone, which could provide an assessment of testicular function."
2,"The NIAID trial is a multinational placebo-controlled trail of 440 hospitalized COVID-19 patients, initially comparing remdesivir with placebo."
2,"A recent case report described the use of remdesivir, requested for compassionate use, in the first patients with COVID-19 in the United States."
0,"Old age, hypertension, interleukin-6, and CD8 + T cell exhaustion were significantly associated with the development of pneumonia."
4,"A first step would be to repeat the in vitro study reported by Caly, Druce (1) with other compounds that could theoretically potentiate ivermectin's inhibition of SARS-COV-2 to ."
2,"Sodium hypochlorite required a concentration of at least 0.21% to be effective."
0,"Whereas ribavirin has no characterized direct CV toxicity, lopinavir/ritonavir may result in QT- and PR-interval prolongation, especially in patients who have a baseline abnormality (long QT) or those who are at risk for conduction abnormalities including those taking other QT prolonging drugs (69)."
2,"Therefore, based on all observations reported in this contribution, it has been concluded that any definitive recommendations regarding the potential clinical utility of identified herein potential coronavirus infection mitigating agents, namelyVitamin D and Quercetin, should be made only after appropriately designed and carefully executed preclinical studies and randomized clinical trials."
4,"Hydroxychloroquine and chloroquine, both antimalarial agents, are being investigated as potential treatments of COVID-19 [3] ."
0,"One of the major pathways for NF-kB activation after coronavirus infection is the MyD88 pathway through pattern recognition receptors (PRRs), leading to the induction of a variety of pro-inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor alpha (TNFa) and chemokines (de Wit et al., 2016) .ACE2 is a membrane protein and inactivator of angiotensin 2 (AngII)."
4,"Sirolimus (Z = -2.35 and GSEA score = 3), an inhibitor of mammalian target of rapamycin (mTOR), was reported to effectively block viral protein expression and virion release effectively [47] ."
4,"Chlorpromazine, an antipsychotic (via dopamine D2 antagonism) dating from the 1950s, is also a potent endocytosis inhibitor (which may explain some of its marked side effects, which can include low white blood cell levels)."
4,"Moreover, the ITC profiles in combination with their chemical structures suggest that baicalin and baicalein act as noncovalent inhibitors of SARS-CoV-2 3CLpro with a high ligand binding efficiency."
4,"Administration of tocilizumab (TCZ), an inhibitor of inflammation that has been suggested for used in COVID-19 by Chinese guidelines for COVID-19, seemed to be able to reverse the changes in PLT transiently in patient P1-P6, except P2, but severe thrombocytopenia recurred a few days after the administration (figure 1A)."
4,"Experts and guides for COVID-19 in China have also recommended chloroquine phosphate superior to the treatment of SARS-CoV-2 infection [8, 9] ."
2,"10 Data from a clinical study of 59 patients with COVID-19 (including 28 severe cases) showed that 63% of patients had proteinuria (mild, 47%; moderate, 10%; severe, 6%); 27% of patients with COVID-19 had elevated urea nitrogen levels and 19% of patients with COVID-19 had elevated serum creatinine levels."
2,"However, it has low aqueous solubility and poor oral bioavailability [56] and despite a higher reported SARS-CoV-2 potency [28] than nitazoxanide [27], the Cmax/EC90 ratio was slightly lower."
4,"In China and South Korea lopinavir 200 mg/ritonavir 50 mg has already been used for the treatment of COVID-19."
4,"Thus, losartan may be suggested as a potential agent of protection from lung damage induced by COVID-19."
4,"Many antivirals, including darunavir and cobicistat, are used off-label in the hospital wards as life-treating medicines for COVID-19 patients."
4,"Anecdotal data suggest patients with SARS-CoV-2 treated with systemic unfractionated heparin or LMWH had better clinical outcomes."
4,"This has led to the initiation of several clinical trials and the off-label use of tocilizumab in symptomatic COVID-19 patients."
2,"Although the long use of this drug in malaria therapy demonstrates the safety of acute chloroquine administration to humans, one cannot ignore the minor risk of macular retinopathy, which depends on the cumulative dose [52] , and the existence of some reports on cardiomyopathy as a severe adverse effect caused by chloroquine [53 , 54] ."
2,"Remdesivir is a monophosphoramidate prodrug of an adenine nucleotide analogue."
2,"Chloroquine was discovered by Hans Andersag in 1934."
2,"A RT-PCR was performed using extracted SARS-CoV-2 376 vRNA to amplify target genes corresponding to Structural and Non-structural proteins 377 of the virus (Table 1, (6)) using Platinum SuperScriptIII One Step RT-PCR system."
2,"Specifically, the mutations eliminate one hydrogen bonding with the receptor, but increase the coordination number (number of contacts) by 20%."
2,"Thus, a three-dimensional model of SARS-CoV 3CLpro in complex with baicalein was constructed by superimposing the crystal structure of SARS-CoV-2 3CLpro/baicalein with that of SARS-CoV 3CLpro/TG-0204998 (PDB code 2ZU4) (Fig."
4,"We previously emphasised interest in chloroquine for the treatment of viral infections in this journal [1] , predicting its use in viral infections lacking drugs."
0,"hydroxychloroquine is that results regarding efficacy in treating SARS-Cov-2 has been conflicting."
4,"Oseltamivir and zanamivir are neuraminidase inhibitors used for treating influenza, that are also being tested in RCT for treating COVID-19 patients (see table 2 )."
4,"Although currently there are noapproved antiviral drugs for the treatment of human coronavirus infections available,preclinical data with the nucleotide analog remdesivir (RDV) are promising, and human safetydata are available (1)."
0,"Prescribing hydroxychloroquine, chloroquine and azithromycin for COVID-19 prophylactic use is discouraged and not recommend by the Boards at this time."
0,"Similarly, the prevalence of death, ARDS, headache, increased leukocyte count, and increased lactate dehydrogenase were significantly higher in studies in which the proportion of older patients was larger (all p<0.05), and the prevalence of diarrhea, and elevated lactate dehydrogenase were significantly higher in studies in which the proportion of patients with any coexisting medical condition was larger (all p<0.05)."
4,"Hydroxychloroquine therapy was started (600 mg BID for 1 day followed by 400 mg daily over the next 4 days), the patient's respiratory status improved, and she was extubated eight hours after SICU admission."
4,"74 In addition, the inhibition of cyclophilins by cyclosporine A could block the replication of coronavirus of all genera, including SARS‐CoV as well as avian infectious bronchitis virus."
2,"We undertook a systematic review and meta-analysis investigating IL-6 dysregulation in patients diagnosed with COVID-19, and the potential role of IL-6 suppression with the administration of tocilizumab."
2,"The multiple molecular mechanisms by which chloroquine can achieve such results remain to be further explored."
0,"However, he failed to improve with standard treatment for ICI-pneumonitis (high dose steroids, infliximab) and was found to have SARS-CoV-2 infection by a nasal swab RT-PCR assay."
0,"Heparininduced thrombocytopenia (HIT) is a well-recognized complication of heparin therapy, and can occur spontaneously, independent of heparin."
4,"The results of our simulations are in line with those of a recent meta analysis of the so far available clinical data, showing that hydroxychloroquine may decrease disease severity but not viral clearance when administered to symptomatic COVID-19 patients [27]  "
4,"The remdesivir has also effectively inhibited virus infection in a human cell line (Huh-7 cells of human liver cancer) that is susceptible to SARS-CoV-265."
2,"ResultsType II membrane serine proteases (TMPRSS)-mediated cleavage can activate the fusion potential of SARS-CoV and MERS-CoV S protein and induce receptor-dependent syncytium formation28,29,38,39."
2,"Considering the current public health crisis, we aimed to unravel the potential drug target, molecular interactions and address the mechanism of action of Arbidol on SARS-CoV-2."
2,"Construction of adenoviral vectors and plasmidsThe codon-optimized gene encoding MERS-S1 (amino acids 1 to 725 of full-length MERS S, according to the GeneBank JX869059) lacking stop codon flanked with SalI & BamHI was amplified by PCR from pAd/MERS-S1 12 and was used to replace the ZIKV-E in in pAd/ ZIKV-Efl 40 at SalI & BamHI sites fused with BamH I-linked T4 fibritin foldon trimerization domain (f), Tobacco Etch Virus Protease (Tp), and six histidine tag (6H), generating plasmid pAd/MERS-S1f."
4,"For instance, Nelfinavir, an HIV-1 protease inhibitor to treat HIV, was prophesied to be a likely inhibitor of 2019-nCoV principal protease by different molecular docking computationalbased [5] ."
0,"Therefore, our findings imply that the development of COVID-19 may cause hepatic impairment in these patients, which is consistent with the observations that a large number of COVID-19 patients showed liver function abnormalities (Table S13 ) (6) .Besides, the reductions of dihydrouracil, an intermediate breakdown product of uracil and guanosine monophosphate (GMP) (29) , are proposed to be caused by the defects of human metabolism."
4,"On this basis, we assessed the safety of baricitinib therapy combined with lopinavir-ritonavir in moderate COVID-19 pneumonia patients and we evaluated its clinical impact."
2,"Fifteen heparin anticoagulated plasma samples (from day 2 to 22 post-symptom onset) 77 from SARS-CoV-2 infected patients were analyzed (Table S1 )."
4,"The latest version (6th edition) of the Guidelines for the Prevention, Diagnosis, and Treatment of COVID-19 by the National Health Commission (NHC) of China has recommended a combination regimen of protease inhibitors (lopinavir and ritonavir) with INF-α."
2,"We have identified 4/33 patients who acquired SARS-CoV-2 while these patients were treated with a PI containing regimen, consisting in boosted darunavir in all cases."
0,"In a recent Comment, Zhang et al[3] have analyzed the effects of the virus on liver and concluded that this pathogen can alter liver enzymes [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)] in 14%-53% of cases, SARS-CoV-2 and as such an infection is present in 2%-11% of patients with known hepatic pathologies (chronic viral hepatitis, nonalcoholic fatty liver disease, alcoholic hepatitis, immune-mediated liver disease).The aim of this mini-review is to identify those studies who have considered liver involvement, especially hypertransaminasemia that occurred during COVID-19 infection, by searching through MEDLINE/PubMed and Google Scholar."
4,"For example, chloroquine, a rheumatological and antimalarial drug currently in clinical trial for COVID-19, has Z-Score=−1.82, indicating its proximity to SARS-CoV2 targets."
2,"Meanwhile, there was no significant increase in serum creatinine in critical group."
2,"Hydroxychloroquine may also exhibit downstream immunosuppressive effects by reducing IL-6 production from T cells and monocytes, 9 which may explain in part its use in autoimmune conditions."
0,"ganciclovir, acyclovir and ribavirin are not valid for 2019-nCoV [ 9]."
4,"In this respect, Wilson et al., showed that hexamethylene amiloride inhibitor has shown to block the E-protein ion channel conductance in cell membrane and inhibits replication of the parent coronavirus in cultured cells (Wilson et al., 2006)."
4,"There are in vitro studies that show both chloroquine and hydroxychloroquine inhibit SARS-CoV-2 in vitro, although hydroxychloroquine appears to be more potent [45]."
4,"Supply shortage of hydroxychloroquine, which remains needed for standard indications such as Lupus or rheumatoid arthritis should be prevented by a significant effort of pharmaceutical companies, already ongoing, for increasing the production of hydroxychloroquine specifically for COVID-19."
4,"A recent study indicated that remdesivir efficiently protected a human cell line against SARS-CoV-2 infection ."
4,"Recently, Elfiky used a computational approach to predict that Sofosbuvir, IDX-184, Ribavirin, and Remidisvir might be potent drugs against ."
2,"It was assumed that the percentage concentration of the cosolvent should not exceed 5% (in the case of ACN, DMSO, MEO, and URE), or should be about 1% in the case of BNZ and PHN phenol (see Supplementary Table S4 )."
0,"Aldosterone in turn increases ACE activity inducing further production of Ang II, leading to a potentially vicious cycle which perpetuates ARDS."
4,"In 22 April 2020 a clinical trial aimed to assess the Baricitinib effectiveness in severe COVID-19 has been authorized by the Italian Drug Agency (AIFA) [https://www.aifa.gov.it/sperimentazioni-cliniche-covid -19] ."
4,"Specifically, we hypothesized that Favipiravir would be superior to Arbidol in terms of improving clinical recovery rate at Day 7, and alleviating pyrexia, cough, and ARDS."
4,"ICMR recommends prophylactic use of hydroxychloroquine 400 mg twice a day on day 1, followed by 400 mg once weekly for next 7 weeksfor HCW managing suspected or confirmed COVID-19 patients [42] ."
4,"Chloroquine has shown to have antiviral activity in vitro and hydroxychloroquine was effective in reducing the viral carriage on day 6 of treatment (Gautret et al., 2020) ."
0,"Oseltamivir was also used in the management of 2019-nCoV; however, definite evidence of efficacy is inconclusive because of lack of suitable control group in the studies."
2,"Tocilizumab is a humanized monoclonal antibody that inhibits both membrane-bound and soluble interleukin-6 (IL-6) receptors."
0,"An earlier IV vitamin C trial of patients admitted to the ICU with pneumonia included hydrocortisone administration [4], however, systemic corticosteroid treatment has not been shown to have significant benefits in patients with COVID-19 [5]."
2,"The role of preparing the nasal and oral cavity with a 0.5% solution of povidone iodine on pledgets for its virocidal properties towards SARS-CoV-2 is unknown at this point in time [24] [25] [26] [27] but is considered an option at our institution."
2,"The patient was admitted with suspected SARS-CoV-2 with a 35 nasopharyngeal swab test of SARS-CoV-2 by polymerase-chain-reaction (PCR) assay pending 36and was started on ceftriaxone and doxycycline due to concern for superimposed bacterial 37"
4,"The recent publication of results showing the activity of chloroquine (CQ) against SARS-CoV-2 in vitro [7] , some experts and researchers also have been recommended the efficacy of this antimalarial drug in patients with COVID-19 [8, 9] ."
4,"We then used the Huh-7 cell model in a 96 well format to test the effects of multiple drugs that have been approved by the FDA for other medical applications, including chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone."
2,"These drugs could form hydrogen bonds with one or more residues among Thr24-Asn28 and Asn119, theoretically, are capable to bind to author/funder."
4,"In addition, remdesivir was effective against many human and zoonotic coronaviruses, including HCoV-NL63, HCoV-OC43, HCoV-229E, mouse hepatitis virus (MHV) ( Betacoronavirus ), SARS-CoV and related bat coronaviruses WIV1 and SHC014 ( Betacoronavirus ), MERS-CoV and related bat coronavirus HKU5, and porcine deltacoronavirus ( Deltacoronavirus ) [17 , 20 , 21] ."
4,"Thus, in view of these results and the urgent clinical demand regarding SARS-CoV-2/COVID-19 pandemia, chloroquine phosphate should be recommended to treat COVID-19 associated pneumonia in larger populations [48] ."
0,"We have already seen other drugs, repurposed for COVID-19, including hydroxychloroquine 6 and lopinavir-ritonavir, 7 report disappointing findings so far in randomised trials after early promise."
4,"Antiviral drugs such as ribavirin, lopinavir-ritonavir have been used based on the experience with SARS and MERS."
0,"Here, we reported that serum IL-6 and lactate at the admission independently predicted poor outcomes of COVID-19 patients, after the adjustment with other significant factors in the univariate Cox analysis (Table 3) ."
4,"It was recently demonstrated that both angiotensin I converting enzyme 2 (ACE2) and the transmembrane protease, serine 2 (TMPRSS2) are crucial for SARS-CoV-2 entry into host cells."
2,"Although it is an approved treatment for influenza, less preclinical support has been established for favipiravir to treat SARS-CoV-2 compared to remdesivir."
2,"In this study, the binding of chloroquine, remdesivir, ribavirin and luteolin with main proteins of 2019-nCoV 5 (3CL protease, PLpro, RdRp, and spike protein) were carried out by computational methods."
4,"Remdesivir is an adenosine nucleotide analogue prodrug with broad-spectrum antiviral activity against filoviruses, paramyxoviruses, pneumoviruses, and pathogenic coronaviruses, like SARS-CoV and MERS-CoV (17)."
2,"In comparison with SARS-CoV, T487 is changed to asparagine (N501) in 2019-nCoV but alanine or serine in the other viruses."
4,"These effects of chloroquine on early phases of viral replication permit the attenuation of vertical transmission in an animal model of Zika virus infection, significantly reducing brain viral load, and make cells refractory to SARS-CoV infection in an in vitro model [4, 5]."
2,"The cellular serine protease TMPRSS2 also contributed to the S-protein priming of 2019-nCoV, indicating that the TMPRSS2 inhibitor might constitute a treatment option36."
4,"Among several potential drugs tested for efficacy in treatment of SARS-CoV-2 infection, 16 remdesivir (GS-5734; Gilead Sciences Inc., Foster City, CA, USA) is shown to be the most promising and hopeful anti-viral therapeutic."
4,"Tenofovir prodrugs are often used in combination with the drug emtricitabine as anti-viral medications."
4,"In the US, an adaptive Phase 2/3, randomized, double-blind, placebo-controlled study assessing efficacy and safety of sarilumab (NCT04315298), another anti-IL-6R antibody started on March 16, 2020, sarilumab binds to both membrane-bound and soluble forms of IL-6R.The clinical presentation of patients with severe forms of COVID-19 resembles cytokine release syndrome (CRS) observed in some oncology patients treated with CAR-T cell therapies."
4,"In summary, the developed PBPK model of nitazoxanide was successfully validated against clinical 370 data and based on currently available data, optimal doses for COVID-19 were estimated to be 700 371 mg QID, 900 mg TID or 1400 mg BID with food."
4,"As of now, remdesivir may be considered in patients with severe disease and respiratory failure (8) ."
0,"One group reported no significant difference in time to viral clearance between patients who received methylprednisolone orally (mild disease) or IV (severe) and those who did not ."
4,"There is currently in vitro evidence that remdesivir may be effective in controlling SARS-CoV-2 infection [56]."
4,"COVID-19 has once again brought remdesivir to the stage of clinical trials."
4,"We describe an algorithm that may help manage this combination therapy to mitigate the risk of TdP and describe the possible use of intravenous lidocaine to permit combination therapy that might not otherwise be possible."
4,"Broad spectrum antiviral drugs have been used in treating COVID-19 infection e.g oseltamivir, lopinavir, ritonavir and ganciclovir regimen; remdesivir and chloroquine regimen (Chen et al., 2020)."
2,"Considering only the Veneto male population ( TMPRSS2 is a member of the family of Type II Transmembrane Serine Proteases (TTSPs) that are involved in multiple physiological and pathological processes, including cancer and viral infections [6] [7] [8] ."
4,"In conclusion, we think that this vinorelbine formulation may be a valuable option allowing to treat frail lung cancer patients during Covid19 era."
4,"Mycophenolate exhibited strong antiviral effects on SARS-CoV and MERS-CoV as demonstrated in vitro studies, with its interaction with viral proteases [98]."
4,"Here, we describe the ability of heparin to inhibit cell invasion and bind the SARS-CoV-2 S1 receptor binding domain (RBD) and investigate the structural requirements and consequences of binding."
4,"Randomised evidence was needed following high-profile publications on the first US COVID-19 case 3 and the subsequent compassionate use of remdesivir in a 53-patient case series, 4 which, coupled with invitro and animal model evidence, had generated high expectations of remdesivir efficacy."
0,"Ribavirin has minimal drug-interactions of note; however, the following may increase the risk for myelosuppression when given in combination with azathioprine, linezolid, and amphotericin B."
2,"Allium sativum (garlic) 42 Quercetin 43 Astragalus membranaceus 44, 45 Mycelium mushroom extracts 46,47 as well as fruiting body extract of Agaricus blazeii 48 Mentha piperita (peppermint) 49 Andrographis paniculata 50 Green tea and green tea extracts 51, 52 Zinc 53 Vitamin A 54 [note: This study found that 25,000iu daily for 4 months in 84 women resulted in lower serum IL-1b and IL-1b/ IL-4 ratios in obese women."
4,"Here we present a 49-year-old male patient with comorbid conditions and presenting with multifocal COVID-19 pneumonia who we successfully treated with hydroxychloroquine."
2,"This is an investigator-initiated, multi-centre, randomised, open-label trial of nebulised heparin sodium in addition to standard care compared to standard care alone in 172 invasively ventilated ICU patients with suspected or confirmed COVID-19 infection."
2,"The data from SARS-CoV-1 are encouraging, but this must be weighed against the inferior performance in mouse models against MERS-CoV, the less potent in vitro activity compared with remdesivir and chloroquine for SARS-CoV-1, and limited data suggesting no advantage over standard care for SARS-CoV-2."
4,"Therefore, repurpose of existing antiviral agents including interferon, chloroquine (an antimalarial agent) and niclosamide (a broad spectrum anthelminthic) have attracted considerable attention and many trials are underway (4, 5) ."
2,"Viral attachment involves an interaction between S and the angiotensin-converting enzyme-2 (ACE2) on the surface of the target cell, and is followed by the priming of S by the cellular serine protease TMPRSS2, also attached to the cellular membrane, which eventually leads to the fusion between the cellular and the viral membranes 1, 6 ."
4,"Remdesivir and chloroquine were found highly effective in vitro for the control of 2019-nCoV infection (44)."
0,"HCQ was reported to increase the risk of neuropsychiatric adverse events when used with the antivirals indinavir, nelfinavir and ritonavir (one of the proposed medicines against SARS-CoV-2 infection) or aminoglycoside antibiotics at doses used for treating rheumatic diseases."
2,"Remdesivir is a nucleoside analog and a broad-spectrum antiviral [3, 38]."
4,"These patients were recruited and screened, and eligible patients were enrolled and treated with danoprevir boosted by ritonavir in the presence or absence of interferon nebulization (as the background therapy) for 4 to12 days until being discharged from the hospital."
2,"48B/2020 emissions of nitrogen oxides into the atmosphere is the combustion of fossil fuels from stationary sources (heating, power generation) and motor vehicles."
4,"After suspension of fingolimod, she developed CRS and acute respiratory distress syndrome (ARDS) and was successfully treated with tocilizumab."
4,"Following the discovery in China of the in vitro activity of chloroquine against SARS-CoV-2, discovered during culture tests on Vero E6 cells with 50% and 90% effective concentrations (EC 50 and EC 90 values) of 1.13 μM and 6.90 μM, respectively (antiviral activity being observed when addition of this drug was carried out before or after viral infection of the cells) [3] , we awaited with great interest the clinical data [14] ."
0,"Recommendation 16: For severe COVID-19 patients with coagulation dysfunction, heparin flush during vascular access placement should be avoided"
2,"In accordance with the recommendations of the National and Regional Health Authority for the pandemic outbreak, CV decided to stay at home, assuming only intermittent therapy to improve myalgia (diclofenac)."
4,"The Italian Drug Agency already triggered several clinical research studies involving remdesivir e tocimizulab and other drugs with originally different therapeutic indications, which -despite great expectations from the public -wait for scientific validation for anti-coronavirus use (5) "
0,"COVID-19 predominantly affects male gender and old age with comorbidities, including especially lung disease, arterial hypertension (AH) and diabetes mellitus (DM) (6) ."
4,"Interestingly, fingolimod, a S1P modulator licensed for MS, is being tested as a treatment for COVID-19 associated ARDS (continued on next page) G. Giovannoni, et al."
4,"12, 13 Other drugs, such as ribavirin, interferon, lopinavir-ritonavir, and corticosteroids that have been used in patients with the 2003 SARS or the 2012 Middle Eastern Respiratory Syndrome, are candidates for investigation."
2,"There are currently 12 registered trials to investigate convalescent plasma or immunoglobulins in COVID-19 (Table 1A : Plasma-Based Therapies).Alternative Treatment Strategies Various other treatment strategies are currently under investigation, including the antifibrotic/inflammatory agent pirfenidone (used in treatment of idiopathic pulmonary fibrosis), and the antiangiogenic agents: bevacizumab (anti-VEGF) and thalidomide (Table 1A : Antifibrotics and Antiangiogenics)."
4,"A huge number of patients are being treated with chloroquine during the COVID-19 pandemic."
0,"In our study, after the patients met the discharge standards of the current COVID-19 treatment scheme (trial version fifth) 8, there were still four patients with absolute value of lymphocytes and two patients with blood phosphorus level not returning to normal."
2,"In the larger case series 56 , 124 patients were treated with oseltamivir combined with antibiotic therapy in 89 patients and combined with glucocorticoids in 62 patients (Appendix 4)."
4,"Remdesivir has been D 1 6 5 X Xapproved by the Food and Drug Administration (FDA) for a National Institutes of HealthD 1 6 6 X X-sponsored randomized controlled clinical trial for hospitalized COVID-19 patients with advanced symptoms (ClinicalTrials.gov identifier NCT04280705)."
4,"The first COVID-19 patient in the USA was successfully treated with remdesivir for the progression of pneumonia on day 7 of hospitalization in January, 2020."
4,"These preliminary results on 12 patients with moderate COVID-19 pneumonia confirmed the safety of baricitinib therapy in a clinical context different from RA 7 ."
4,"We tested the ability of the active triphosphate forms of both tenofovir and emtricitabine to be incorporated by the SARS-CoV-2 RdRp."
4,"Regeneron Pharmaceuticals and Sanofi are also conducting a phase II and a phase III trial on Kevzara (sarilumab), an IL-6 receptor antagonist, in severe and critical COVID-19 patients (NCT04315298)."
4,"In a lethal murine model of MERS, remdesivir was superior to a regimen of combined interferon beta and lopinavir-ritonavir."
4,"Preliminary results showed that chloroquine phosphate had apparent efficacy in treatment of COVID-19 73."
2,"Similarly, induction with liposomal daunorubicin and cytarabine can be administered as an outpatient in patients with AML following MDS, therapy-related AML, or those with MDS-related cytogenetic abnormalities."
4,"Notably, inhibition of mTOR with sirolimus reduced MERS-CoV infection by ~60% in cell-based studies 21 ."
0,"They argued that coronaviruses bind to angiotensin-converting enzyme-2, and ibuprofen administration can increase the bioavailability of angiotensin-converting enzyme-2, therefore potentiating and enhancing the infectious processes of coronaviruses."
4,"One promising example could be remdesivir, which interferes with the viral polymerase and has shown efficacy against MERS in mouse models33."
0,"In this regard, one of the hottest controversies is the hydroxychloroquine (HCQ) efficacy for the COVID-19 patients."
2,"It is also necessary to determine whether the benefit of chloroquine therapy depends on the age of the patient and the clinical presentation or stage of the disease [70] ."
0,"Baricitinib, for example, is a rheumatological drug currently in trial for COVID-19 and all diffusion-based pipelines rank it higher than tocilizumab, a drug also indicated for rheumatological and severe inflammatory diseases with no proven COVID-19 relevance."
4,"Remdesivir (GS-5734) is a 1′-cyano-substituted adenosine nucleotide analog prodrug and shows broad-spectrum antiviral activity against several RNA viruses."
2,"Furthermore, it is also not clear how remdesivir can evade the proofreading activity of SARS-CoV-2 to prevent itself from being cleaved by ExoN.To elucidate the mechanisms of remdesivir inhibition on RdRp and ExoN, we conducted an aggregation of 12.6 µs all-atom molecular dynamics (MD) simulations of the nsp12-nsp7-nsp8 and nsp14-nsp10 complexes in SARS-CoV-2."
2,"angiotensin converting enzyme 2 [ACE2] or transmembrane serine protease 2 [TMPRSS2], essential host proteins for SARS-CoV-2 priming and cell entry (66) to modulate the host-pathogen interface."
2,"In January 2020, a 53-year-old gentleman with a background of asthma on long-term low dose inhaled corticosteroid inhaler had an acute exacerbation of his asthma in February 2020 triggered by a viral upper respiratory tract infection and acute sinusitis and was managed with bronchodilator nebulization and a 7-day course of oral prednisone 30 mg daily."
4,"Furthermore, also amiodarone has been suggested as a possible inhibitor of SARS coronavirus spreading by its ability to interfere with the endocytic pathway [28]."
4,"Currently a large clinical trial is taking place, where thousands of health workers will receive CQ or hydroxychloroquine (HCQ) to assess the two drugs' prophylactic potential (6) ."
4,"A rapid influenza test, conducted simultaneously, was positive for influenza A virus, and she was started on oseltamivir with ceftriaxone 2 g/day and azithromycin 500 mg/day to cover possible bacterial infections."
2,"We identify a distinct four residue insert (featuring two arginine residues) that maps to the S1/S2 priming loop of SARS-CoV-2, which is missing from all other SARS-CoV-related viruses but present in MERS-CoV S and in many other coronaviruses."
2,"Conclusion: The implications fingolimod has on COVID-19 are complex."
0,"They reported that 14.4% of the COVID-19 patients in the study showed elevated levels of serum creatinine upon admission."
2,"The concentration of teicoplanin required to inhibit 50% of viruses (IC 50 ) in vitro was 1.66 μM, which is much lower than the concentration reached in human blood (8.78 μM for a daily dose of 400 mg) [7] ."
2,"In addition, pitavastatin, perampanel, and praziquantel might author/funder."
2,"Furthermore, this study supports the repurposing of heparin and its derivatives as antiviral agents, to provide a rapid countermeasure against the current SARS-CoV-2 outbreak and future emerging viral diseases."
2,"Therefore, non-immunosuppressive derivatives of cyclosporine A might serve as broad-range CoV inhibitors applicable against emerging virus like 2019-nCoV, which still needs to be confirmed by clinical studies in the future."
2,"The scope of these guidelines will change based on emerging data from our colleagues in other specialties, such as whether thromboprophylaxis regimes, or the process of taking informed consent need to be altered in patients requiring intravenous immunoglobulin therapy, given the concerns about prothrombotic states in COVID-19.Moreover, given the possibility that a significant driver of pathology may be related to an overactive immune state, it remains an open question whether certain immunosuppressive agents may be beneficial, such as has been suggested in a case report of ocrelizumab in multiple sclerosis [51] ."
4,"Combination therapy with 2019-nCoV specific monoclonal antibodies and remdesivir can be considered as the ideal therapeutic option for 2019-nCoV (Cohen 2020)."
4,"On February 5, 2020,a phase 3 randomized, quadruple-blind, placebo-controlled clinical trial was registered atCapital Medical University, with the goal to determine safety and efficacy of remdesivir inpatients with mild to moderate SARS-CoV-2 infection (NCT04252664, since suspended).78 A day later, a second trial (NCT04257656, since terminated) was registeredat the same location, focused on patients with advanced COVID-19 respiratory disease."
4,"The recent integrative antiviral drug repurposing analysis implicated another ARB—irbesartan—as a potential repurposable medication for COVID-19 hypokalaemia was reported as a fairly common manifestation of COVID-19 (possibly through increased kaliuresis rather than gastrointestinal loss).38 Hypokalaemia in COVID-19 patients is difficult to manage, correlates with the severity of the disease, and has been suggested to be driven by activation of the RAAS.38 ACEIs or ARBs might offer some protection in this setting."
4,"Remdesivir is an anti-viral that was seen to both prevent and treat infection caused by MiddleEast respiratory syndrome coronavirus in monkeys (76) ."
4,"In a cohort of patients hospitalized for severe Covid-19 who were treated with compassionate use remdesivir, clinical improvement was observed in 36 of 53 patients (68%) [25]."
4,"While anecdotal, hydroxychloroquine and azithromycin have shown potential in both prophylaxis and treatment of patients with COVID-19."
4,"Disinfection could therefore be achieved using 30 minutes at 56 o C, ether, 75% ethanol, chlorine-containing disinfectants, peracetic acid, or chloroform."
4,"Remdesivir (GS-5734), (CAS number: 1809249-37-3), is a novel small-molecule adenine nucleotide analogue antiviral drug that has shown efficacy against Ebola virus in rhesus monkeys."
2,"If these clinical trials have been adequately performed and their results are convincing, they are either in press or will be published very soon in a top-tier scientific journal, just like the recent article evaluating lopinavir and ritonavir published in the New England Journal of Medicine."
4,"Further, some patients tested positive for influenza virus antibodies, so oseltamivir antiviral therapy was used."
2,"This article starts from the structure, immunogenicity, and pathogenesis of infection of the SARS-CoV-2, and then analyzes the feasibility of conducting trials and putting into clinical use of COVID-19 from the pharmacological characteristics and successful cases of remdesivir."
0,"In December 2019, a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged from China causing pneumonia outbreaks, first in the Wuhan region of China and then spread worldwide because of its probable high transmission efficiency."
0,"However, COVID-19 patients treated with methylprednisolone were sicker and had a higher pneumonia severity index than those patients who did not receive methylprednisolone."
0,"As the majority of our patients (22/33) was treated with tenofovir alafenamide or tenofovir disoproxil fumarate, including those developing severe or critical disease, our cohort data indicate no or only minimal clinical effect of tenofovir against SARS-CoV-2"
2,"The ChAdOx1 nCoV-19 vaccine, produced in a partnership between The University of Oxford's Jenner Institute and Italian pharmaceutical manufacturer Advent Srl, consists of an attenuated adenovirus capable of producing the spike (S) protein of SARS-CoV-2, allowing for the formation of endogenous antibodies against these proteins and, consequently, against SARS-CoV-2 [80] .Currently, there is no conclusive evidence that ibuprofen and other anti-inflammatory drugs increases the risk of serious complications or of acquiring the virus that causes COVID-19."
2,"An analysis of the structure of SARS-CoV-2 complex with ACE2, reveals that most hydrogen bonds between protein S and ACE2 involve the helix H1 (residues 20-52) and the C-terminal part of helix H2 (residues 56-82) of ACE2 [10] ."
0,"Indeed, hydroxychloroquine use in Covid-19 patients has been associated with cardiac toxicity."
0,"Interestingly, hydroxychloroquine (Plaquenil), an antimalarial drug, has also been reported to downregulate the expression of toll-like receptors (TLRs) and IL-6 production, and therefore may have potential anti-COVID-19 activity [supplementary materials 3]."
2,"The potential use of endocytosis inhibitors such as Amiodarone (Stadler et al., 2008) and chlorpromazine in coronavirus infection is further discussed here .The situation with targeting autophagy seems unclear."
4,"This approach proved feasible for combating the Zika, yellow fever and chikungunya outbreaks experienced in Brazil over the past 5 years, when our group demonstrated that sofosbuvir, a blockbuster drug against hepatitis C, could represent a compassionate countermeasure against these diseases [25] [26] [27] [28] [29] .Currently, the rate of SARS-CoV-2 dissemination has become one of the most rapidly evolving pandemics known in modern times with the number of cases and deaths doubling every week and the peak of the pandemic has yet to arrive 6 The copyright holder for this preprint (which was not peer-reviewed) is the ."
4,"Broad-range combinational therapies, including lopinavir and interferon antiviral peptides, can also be evaluated and examined, as these agents have shown significant effects against MERS in nonhuman primates (1)."
2,"Although there is currently no known effective treatment for COVID-19, reports of the use of oseltamivir, lopinavir/ritonavir, and antibiotics have been reported despite the WHO making no recommendation for the use of antiviral drugs, antibiotics, or glucocorticoids (22) ."
2,"It involves use of horseradish peroxidase conjugate (ENZO, catalogue #ADI-950-113-0100) and an HRP-conjugated compact polymer system, with DAB as chromogen."
0,"reported their case series of 5 COVID-19 cases in France, of whom 3 with at least severe illness requiring ICU monitoring received remdesivir."
4,"Tocilizumab is known to improve insulin resistance and reduce HbA1c in patients with rheumatoid arthritis and diabetes mellitus (42) ."
2,"Remdesivir is now being tested in several clinical trials designed to evaluate its efficacy and safety for the treatment of COVID-19."
2,"This analysis provides a rational dose optimisation for nitazoxanide for treatment and prevention of 341 COVID-19."
2,"Both servers predictions were consistent and provide six possible positions where a Arbidol could potentially interact with the spike glycoprotein ( Fig."
4,"In vitro cell cultures, HCQ seems to be a more potent inhibitor of infection with SARS-CoV-2 than chloroquine (14, 15)."
